Companies
Franz Ziel
the PROLine Isolator integrates with PAS-X manufacturing execution system software, extending the isolator into a digitally connected production node balancing containment with aseptic design.
- Country
- Germany
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
| cleanroom-facilities | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | 29.1 million EUR (as of 2024) | firmendata.com |
| Headcount | 389 employees (as of March 2026) | firmendata.com |
| Production site | Billerbeck, Germany (headquarters) and Rock Hill, South Carolina, USA (subsidiary) | firmendata.com · koerber-pharma.com · ziel-gmbh.com |
| Capacity | Expansion with another production hall in 2025 | ziel-gmbh.com |
| Certification | PAS-X MSI Plug & Produce Ready certification (as of March 2024) | koerber-pharma.com · ziel-gmbh.com |
| Regulatory approval | Acquisition of a minority share by Körber AG was subject to customary closing conditions and regulatory approvals (as of December 2023) | koerber-pharma.com |
Independent sources: firmendata.com · koerber-pharma.com · ziel-gmbh.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aseptic isolators for pharma manufacturing | analytics-pat | Low | → |
| Pass-through chambers and airlocks | cleanroom-facilities | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.